UK: Early success in cancer drug trial gives patients ‘promising’ future

A London hospital’s trial of a prostate cancer drug has been stopped early   because it was so successful doctors felt it would be “unethical” to deny   the treatment to other patients.

Medics halted tests of the life-extending drug because it would have been   “unethical” not to offer the treatment to all 922 cancer sufferers taking   part in the trial.

Patients who were given the drug found that it eased pain and caused only   minor side effects.

The new drug accurately targets tumours using alpha radiation, which doctors   conducting the study said is the most effective form of radiation to   eliminate cancer because it limits damage to surrounding tissue.

Dr Chris Parker, lead researcher on the project at the Royal Marsden Hospital, said: “It’s more damaging. It takes one, two, three hits to kill a cancer cell compared with thousands of hits for beta particles.”  The drug, Radium-223 Chloride – known as Alpharadin TM – will also do less   damage to surrounding tissue because it accurately targets calls, the   doctors said.


Categories: Health, UK

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.